Infectious DiseasesDirect-Acting Antiviralsantiviral prophylaxis
Efficacy and Outcomes of Short-Course Perioperative Antiviral Prophylaxis in Hepatitis C Viremic Donor Kidney Transplantation
By MedXY|Aug 20, 2026
A 7-day perioperative sofosbuvir/velpatasvir prophylaxis in HCV-positive donor to HCV-negative recipient kidney transplants demonstrated sustained virologic response in over 92% of cases, with favorable 1-year graft survival and function.
